[{"orgOrder":0,"company":"Endoceutics","sponsor":"Cosette Pharma","pharmaFlowCategory":"D","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"CANADA","productType":"Hormone","year":"2023","type":"Acquisition","leadProduct":"Prasterone","moa":"steroids (androgens","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Approved FDF","graph3":"Endoceutics","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Vaginal Insert","sponsorNew":"Endoceutics \/ Cosette Pharma","highestDevelopmentStatusID":"15","companyTruncated":"Endoceutics \/ Cosette Pharma"},{"orgOrder":0,"company":"AMAG Pharmaceuticals","sponsor":"Millicent Pharma","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"U.S.A","productType":"Hormone","year":"2020","type":"Divestment","leadProduct":"Prasterone","moa":"steroids (androgens","graph1":"Neurology","graph2":"Approved FDF","graph3":"AMAG Pharmaceuticals","amount2":0.13,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Neurology","amount2New":0.13,"dosageForm":"Vaginal","sponsorNew":"AMAG Pharmaceuticals \/ Millicent Pharma","highestDevelopmentStatusID":"15","companyTruncated":"AMAG Pharmaceuticals \/ Millicent Pharma"},{"orgOrder":0,"company":"Theramex","sponsor":"Endoceutics","pharmaFlowCategory":"D","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"UNITED KINGDOM","productType":"Hormone","year":"2022","type":"Partnership","leadProduct":"Prasterone","moa":"steroids (androgens","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Approved FDF","graph3":"Theramex","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Vaginal Pessary","sponsorNew":"Theramex \/ Endoceutics","highestDevelopmentStatusID":"15","companyTruncated":"Theramex \/ Endoceutics"},{"orgOrder":0,"company":"Lee Pharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"INDIA","productType":"Hormone","year":"2021","type":"Inapplicable","leadProduct":"Prasterone","moa":"steroids (androgens","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase III","graph3":"Lee Pharma","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Vaginal Suppository","sponsorNew":"Lee Pharma \/ Inapplicable","highestDevelopmentStatusID":"10","companyTruncated":"Lee Pharma \/ Inapplicable"}]

Find Clinical Drug Pipeline Developments & Deals for Dehydro-epi-androsterone

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check COS database
Check all USDMF suppliers

Contact Us
PharmaScopic.com

Dehydro-epi-androsterone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 2 USDMF, 4 EU WC, 13 NDC API, 5 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 1 FDA Orange Book, 2 Europe, 1 Canada

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 2 Gangwal Healthcare, 1 Pfanstiehl, 2 Kirsch Pharma, 3 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 1 CD Formulation, 2 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures, 3 Kerry, 1 Keval Exports, 7 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 8 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 13 Thickeners and Stabilizers, 10 Direct Compression, 9 Lubricants & Glidants, 8 Co-Processed Excipients, 7 Granulation, 6 Parenteral, 5 Taste Masking, 5 Coating Systems & Additives, 4 Disintegrants & Superdisintegrants, 4 Controlled & Modified Release, 4 Chewable & Orodispersible Aids, 2 Film Formers & Plasticizers, 2 Topical, 1 API Stability Enhancers, 1 Rheology Modifiers, 1 Emulsifying Agents

DIGITAL CONTENT

9 News #PharmaBuzz

9 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 2 Health Canada Patents

Xls

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Lee Pharma

India

CPhI WW Frankfurt

Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.

Lead Product(s) : Prasterone

Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

Study Phase : Phase III

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

A Clinical Study of INTRAROSAÂ® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy

Details : Undisclosed

Product Name : Undisclosed

Product Type : Hormone

Upfront Cash : Inapplicable

July 29, 2021

Lead Product(s) : Prasterone

Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

Highest Development Status : Phase III

Sponsor : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

Endoceutics

Canada

BIOHK2025

Not Confirmed

03

Theramex

United Kingdom

BIOHK2025

Not Confirmed

04

AMAG Pharmaceuticals

U.S.A

BIOHK2025

Not Confirmed

05

Olivia Cardenas-Trowers, M.D.

Country

BIOHK2025

Not Confirmed

06

Center for Vulvovaginal Disorders

Country

BIOHK2025

Not Confirmed

07

Endoceutics

Canada

BIOHK2025

Not Confirmed

08

Endoceutics

Canada

BIOHK2025

Not Confirmed

09

Endoceutics

Canada

BIOHK2025

Not Confirmed

10

Endoceutics

Canada

BIOHK2025

Not Confirmed